Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /524506
chevron_leftBack
Coral Laboratories Ltd. logo

Coral Laboratories Ltd.

524506
BSE: 524506 Delayed
421.10INR 0.2%
4.40 USD
As of 5 June 2026, Coral Laboratories Ltd. has a market cap of $15.71M USD, ranking #38708 globally and #2839 in India. It ranks #3451 in the Healthcare sector, and #223 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
38708
Country Rank
2839
Sector Rank
3451
Industry Rank
223
Key Stats
Market Cap
$15.71MUSD
1.5B INR
Enterprise Value
$5.12MUSD
490.0M INR
Revenue (TTM)
$9.14MUSD
875.55M INR
EBITDA (TTM)
$1.25MUSD
119.78M INR
Net Income (TTM)
$1.46MUSD
139.84M INR
EBITDA Margin
14%
Profit Margin
16%
PE Ratio
10.8
PS Ratio
1.7
PB Ratio
0.7
EV/EBITDA
4.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Girish Dhameja open_in_new
Employees
197
Founded
1994
Website
corallab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.2% -1.6% 16% -4.7% -13% -37%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
524506 (CORALAB)
Coral Laboratories Ltd
ISIN: INE683E01017
Shares Out.:
3.573M1 Shares Float: 1.018M2
TV:
SA:
YF:
GF:
BA:
MS:
421.10 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Coral Laboratories Ltd.

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products. It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
CIPLA
$11.12B
1.06T INR
71K%
23.4
LUPIN
$11.0B
1.05T INR
70K%
22.7
AUROPHARMA
$8.43B
807.02B INR
54K%
23.1
SUVENPHAR
$1.87B
178.87B INR
12K%
199.0
GRANULES
$1.83B
174.85B INR
12K%
32.1
SEQUENT
$944.92M
90.48B INR
6K%
92.7
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
240K%
24.2
$29.56B
188K%
-
$15.86B
107.34B CNY
101K%
16.0
$9.1B
61.6B CNY
58K%
80.6
$8.79B
7.57B EUR
56K%
-
$5.22B
35.33B CNY
33K%
20.0
chevron_leftBack